Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
to join our team for a 10-month, full-time internship starting in August/September 2025. The exact starting date and length of the internship can be discussed. As part of our Communications team, you will
-
We invite applications for a PhD position in computer-aided drug design at the Computational Pharmacy Group, Department of Pharmaceutical Sciences, University of Basel. This position is part of
-
part of a large international research center in collaboration with Denmark Technical University and University of Copenhagen and bridges our activities in the fields of nanocelluloses, proteins and
-
would like to be part of a highly motivated, young team, we would be pleased to receive your online application, including the following documents: CV (mandatory) Transcripts (mandatory) A motivation
-
biomedical applications. We also develop experimental techniques to observe and characterise high-speed multiphase fluid phenomena optically and acoustically. The group is part of the Institute of Fluid
-
technologically cutting-edge topic of high relevance and novelty, with direct access to state-of-the-art research infrastructure and equipment. As part of an experienced and multidisciplinary project team with
-
) named gt4py. Job description As an HPC software developer you will work on the modelling infrastructure and port some components of the model using compiler directives, particularly within the data
-
. Workplace Workplace We offer Your career with impact: Become part of ETH Zurich, which not only supports your professional development, but also actively contributes to positive change in society. We
-
deposition towards Se speciation. The focus will be on transformation pathways of atmospheric Se compounds that govern the chemical form of Se in aerosol particles and precipitation. An essential component of
-
, control engineering, and immunoengineering. This position is part of our newly funded ERC Advanced Grant, which aims to develop genetically engineered feedback control circuits in human T cells to tackle